Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes (Q83292729)
Jump to navigation
Jump to search
scientific article published on 01 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes |
scientific article published on 01 February 2009 |
Statements
Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes (English)
Richard E Pratley
1 February 2009